-
The application for an extension of glyphosate was rejected twice, and the European Commission decided to approve its temporary renewal for another year
Time of Update: 2022-11-25
On November 1 Chinese 5, EU member states again rejected the European Commission's proposal to extend the marketing license for the herbicide glyphosate for another year, but the European Commission said it would still approve its provisional renewal by mid-December.
-
Thrombolysis, thrombectomy or combination, how to choose the treatment of large-vessel occlusive ischemic stroke
Time of Update: 2022-11-05
In order to further enhance the public's understanding of stroke, "Medical Neurology Channel" and "Shanghai Changhai Hospital" held this event, and this article invited Professor Yang Pengfei from Shanghai Changhai Hospital to answer our questions about large-vessel occlusive ischemic stroke (AIS-LVO).
-
The groundbreaking ceremony for the annual output of 160,000 tons of polyurethane project of Shandong Xuzheng New Materials Co., Ltd. was held
Time of Update: 2022-11-02
, Ltd. started construction of a polyurethane project with an annual output of 160,000 tonsIn his speech, Chen Zhiyuan congratulated Xuzheng New Materials Co.
, Ltd. started construction of a polyurethane project with an annual output of 160,000 tonsIn his speech, Chen Zhiyuan congratulated Xuzheng New Materials Co.
-
NSCLC backline refractory? Sulfatinib is expected to break the dilemma or bring new dawn to patients| 2022 ESMO
Time of Update: 2022-09-21
*For medical professionals only2022 ESMO Sulfatinib new attempts, results at a glance. Lung cancer is the leading cause of cancer death worldwide, and the treatment strategy for lung cancer depends pr
-
The total investment is 300 million yuan
Time of Update: 2022-09-13
meaning Zhang Qiang said in his speech that the launch of the second phase of the BOPA film project with an annual output of 25,000 tons of Nylon Materials (Suiping) is a fruitful achievement in the Suiping new material industry and is of great importance to promoting the high-quality development of Suiping's manufacturing industry.
-
With frequent personnel changes, domestic pharmaceutical companies have ushered in major adjustments
Time of Update: 2022-05-02
For example, on February 23, Guangshengtang announced that the company recently appointed George Zhang (Zhang Yuhua) as the company's innovative drug holding subsidiary Fujian Guangsheng Zhonglin Biotechnology Co.
-
Sales revenue of pig breeding companies fell in January
Time of Update: 2022-03-04
The reporter noticed that the sales revenue of many pig companies declined year-on-year, and the industry generally attributed it to the decline in live pig prices .
On the same day, Tiankang Biology announced that in January, the company sold 126,900 live pigs, with sales revenue of 186 million yuan, down 17.
-
Professor Hu Qun keeps pace with the times and adapts measures to local conditions. The new version of the Chinese Children’s ITP Guidelines has been released, and the standardized diagnosis
Time of Update: 2021-12-07
In order to further improve the level of children's ITP diagnosis and treatment in China, experts in the field of children's blood have issued new guidelines that clarify the treatment goals: more than just To increase the platelet count, it is important to stop bleeding, reduce adverse drug reactions, and improve the quality of life of patients .
-
FDA approves emergency use of Comirnaty in children aged 5 to 11 years
Time of Update: 2021-11-12
The FDA this Friday authorized the emergency use of Pfizer and BioNTech's Comirnaty to prevent COVID-19 , including children aged 5 to 11 .
Pfizer and BioNTech recently reported data from a Phase II/III study, showing that Comirnaty is 90.
-
The Sci-tech Innovation Board has tightened supervision, and another pharmaceutical company's IPO has been denied
Time of Update: 2021-09-30
Following the rejection of the Haihe Pharmaceutical Science and Technology Innovation Board IPO on September 17, another pharmaceutical company was rejected recently . On September 22, public inform
-
Zheng Xiangling, Chairman of Beijing Tide Pharmaceuticals, was elected as a member of the Hong Kong Special Administrative Region Election Committee
Time of Update: 2021-09-30
On September 19, the 2021 election of the Hong Kong Special Administrative Region Election Committee was successfully concluded.
Zheng Xiangling, executive director of the China Overseas Friendship Association and chairman of the Hong Kong Provincial Committee of the CPPCC Committee, said that the election of the Election Committee was carried out smoothly and orderly.
-
Jining New Material Industrial Park: Planning first and going "high" all the way
Time of Update: 2021-07-14
High starting point design park planning Dong Shengping, deputy director of the Management Committee of Jining New Material Industrial Park, told the research team that at the beginning of its establishment, the park invited domestic advanced experts from the Shanghai Chemical Industry Park to carry out high-standard planning and high-quality construction of supporting projects, and use the "three-level expert review" to select high requirements.
-
The founding meeting of the Professional Committee of Machinery and Equipment of China Condiment Association was held in Yangxi
Time of Update: 2020-12-26
the establishment of the Special Committee on Machinery is of great significance to promote the innovation and healthy development of China's machinery and equipment industry and the cooperation and exchange between condiment manufacturers and machinery and equipment enterprises.
-
Luzhou "The Capital of Chinese Medicine in the World" construction road map out
Time of Update: 2020-03-20
the "World Capital of Traditional Chinese Medicine (Anhui Luzhou) Construction and Development Plan (2020-2030)" has been approved and issued "Planning" proposed that by 2030, and strive to achieve
-
Function indications, usage and dosage, notice of 91 varieties
Time of Update: 2019-09-24
Our commission now publicizes the relevant medical contents of the new and revised varieties in the first part of the Chinese Pharmacopoeia (2020 version) (see the appendix for details) The publicity
